…se patients remains unexplored. In a phase 1 open-label trial ( NCT06414135), we assessed relmacabtagene autoleucel (relma-cel) in progress…
All extracted institutions
Showing 721–780 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.
Articles mentioning institutions
11,350 articles · page 476 of 946….Material and Methods CAR T cells were produced in our academic Good Manufacturing Practice laboratory with a human anti-CD19 lentiviral construct and amplification i…
… ASTIS protocol between September 2011 and November 2024 at two Dutch university hospitals were analysed retrospectively. CRS was graded according to the …
…ase in mRSS.Patients received anti-CD19 CAR-T cells produced at Sheba Medical Centre using an FMC63-28-CD3zeta CAR. Following lymphodepletion with f…
…ing and random selection within the observational cohort study; STRIKE (IRAS ID: 178638). Eligible patients aged 18-70 years of age wi…
…ole of B-cells in the pathogenesis. The aim of LIBERIUS study ( NCT05726630) was to evaluate the efficacy and safety of Divozilimab (DIV), …
…bed [Müller et al., 2024]. Patients received the therapy at the University hospital Erlangen as part of the CASTLE study [Schett et al., 2024]. Immunosuppre…
…er 24-weeks, followed by a 28-week open-label extension (OLE) ( NCT06843239).Approximately 80 adults aged 18–75 years with dcSSc less than/…
…rosis who were hospitalized in the rheumatology department of a university hospital over a one-year period. In order to collect the data, a review …
…odified Rodnan skin score (mRSS) 16±12, disease activity (ESSG, European Scleroderma Study Group) 3.9±2.0 with progressive skin thickening and/or arthritis and/…
…atient representatives from the National Association for Lupus, APS, Scleroderma and MCTD.Results The comprehensive guideline addre…
…Sc according to the ACR/EULAR 2013 criteria, recruited from two Italian Rheumatology centers. Patients were grouped based on HCQ treatment. Demographic, cli…